Rocco Raffaele

Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death

Valeria Bruno, Agata Copani, Giuseppe Battaglia et al. · European Journal of Pharmacology · 1994 · 121 citations

Excitotoxic Neuronal Death, Neurophysiology, Medicine +12

The SSRI, Citalopram, Improves Bradykinesia in Patients With Parkinson's Disease Treated with L-Dopa

Liborio Rampello, Santina Chiechio, Rocco Raffaele et al. · Clinical Neuropharmacology · 2002 · 91 citations

Prediction of the response to citalopram and reboxetine in post-stroke depressed patients

Liborio Rampello, Santina Chiechio, Giovanni Federico Nicoletti et al. · Psychopharmacology · 2004 · 87 citations

Psychiatry, Mood Symptom, Medicine +13

An evaluation of efficacy and safety of reboxetine in elderly patients affected by “retarded” post-stroke depression

Liborio Rampello, Alessandro Alvano, Santina Chiechio et al. · Archives of Gerontology and Geriatrics · 2004 · 68 citations

” Post-stroke Depression, Psychiatry, Elderly Patients +9

Evaluation of the Prophylactic Efficacy of Amitriptyline and Citalopram, Alone or in Combination, in Patients with Comorbidity of Depression, Migraine, and Tension-Type Headache

Liborio Rampello, Alessandro Alvano, Santina Chiechio et al. · Neuropsychobiology · 2004 · 56 citations

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +16